Montagu Hankin is an experienced professional in program management within the pharmaceutical and biotechnology sectors. Currently serving as Senior Director of Program Management at Keros Therapeutics since November 2021, Montagu previously held senior roles at Inozyme Pharma and Apellis Pharmaceuticals, among others. With a strong foundation as a Clinical Research Associate at ORA Clinical Research and extensive experience in clinical trial management and project management, Montagu has developed a robust skill set in leading programs and teams in the development of innovative therapies. Montagu holds an MBA/MS in Biotechnology from The Johns Hopkins University and a BA in Biology from Colby College.